These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24841877)

  • 1. Resveratrol and diabetes.
    Vallianou NG; Evangelopoulos A; Kazazis C
    Rev Diabet Stud; 2013; 10(4):236-42. PubMed ID: 24841877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of resveratrol in diabetes: rationale, strategies and challenges.
    Bagul PK; Banerjee SK
    Curr Mol Med; 2015; 15(4):312-30. PubMed ID: 25941821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and diabetes: from animal to human studies.
    Szkudelski T; Szkudelska K
    Biochim Biophys Acta; 2015 Jun; 1852(6):1145-54. PubMed ID: 25445538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant foods and herbal sources of resveratrol.
    Burns J; Yokota T; Ashihara H; Lean ME; Crozier A
    J Agric Food Chem; 2002 May; 50(11):3337-40. PubMed ID: 12010007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
    Chi TC; Chen WP; Chi TL; Kuo TF; Lee SS; Cheng JT; Su MJ
    Life Sci; 2007 Apr; 80(18):1713-20. PubMed ID: 17346750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and diabetes: A critical review of clinical studies.
    Öztürk E; Arslan AKK; Yerer MB; Bishayee A
    Biomed Pharmacother; 2017 Nov; 95():230-234. PubMed ID: 28843911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of resveratrol in diabetes and obesity associated with insulin resistance.
    Hoca M; Becer E; Vatansever HS
    Arch Physiol Biochem; 2023 Apr; 129(2):555-561. PubMed ID: 33719825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and bioavailability of trans-resveratrol.
    Wenzel E; Somoza V
    Mol Nutr Food Res; 2005 May; 49(5):472-81. PubMed ID: 15779070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms.
    Kumar A; Negi G; Sharma SS
    Curr Med Chem; 2013; 20(36):4640-5. PubMed ID: 24206125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.
    Côté CD; Rasmussen BA; Duca FA; Zadeh-Tahmasebi M; Baur JA; Daljeet M; Breen DM; Filippi BM; Lam TK
    Nat Med; 2015 May; 21(5):498-505. PubMed ID: 25849131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.
    Turan B; Tuncay E; Vassort G
    J Bioenerg Biomembr; 2012 Apr; 44(2):281-96. PubMed ID: 22437738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicity of effects and health benefits of resveratrol.
    Kuršvietienė L; Stanevičienė I; Mongirdienė A; Bernatonienė J
    Medicina (Kaunas); 2016; 52(3):148-55. PubMed ID: 27496184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol vs. calorie restriction: data from rodents to humans.
    Lam YY; Peterson CM; Ravussin E
    Exp Gerontol; 2013 Oct; 48(10):1018-24. PubMed ID: 23624181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of endothelial nitric oxide synthase (eNOS), silent mating type information regulation 2 homologue 1 (SIRT1) and autophagy-related genes by repeated treatments with resveratrol in human umbilical vein endothelial cells.
    Takizawa Y; Kosuge Y; Awaji H; Tamura E; Takai A; Yanai T; Yamamoto R; Kokame K; Miyata T; Nakata R; Inoue H
    Br J Nutr; 2013 Dec; 110(12):2150-5. PubMed ID: 23750556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: evidence for pivotal role of metabolic disturbances.
    Szkudelski T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E901-7. PubMed ID: 17578889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.
    Huang JP; Huang SS; Deng JY; Chang CC; Day YJ; Hung LM
    Free Radic Biol Med; 2010 Dec; 49(11):1710-21. PubMed ID: 20828608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-diabetic effects of resveratrol.
    Szkudelski T; Szkudelska K
    Ann N Y Acad Sci; 2011 Jan; 1215():34-9. PubMed ID: 21261639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
    Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE
    Diabet Med; 2013 Oct; 30(10):1214-8. PubMed ID: 23663119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol, obesity and diabetes.
    Szkudelska K; Szkudelski T
    Eur J Pharmacol; 2010 Jun; 635(1-3):1-8. PubMed ID: 20303945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.